Back

Effect of empagliflozin on no-reflow in patients with st elevation myocardial infarction undergoing primary percutaneous coronary intervention

1 September 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications Revascularisation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mostafa Ayman

Ain Shams University Hospital, Cairo (Egypt)

9 More presentations in this session

Presentation thumbnail
Relationship between lipoprotein(a) and endogenous fibrinolytic status in patients with STEMI
Doctor J. Leader (Stevenage, GB)
Abstract Slides Video
Presentation thumbnail
The clinical characteristics and prognosis of patients with acute non-ST-segment elevation myocardial infarction complicated with impaired activity daily living
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
ORBI risk score and inflammatory response in patients with acute ST-elevation myocardial infarction
Doctor J. Kunkel (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Combined activation of complement and coagulation is associated with myocardial injury in ST-elevation myocardial infarction
Mr K. Kluge (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with STEMI: new kids on the block
Doctor G. Civieri (Padova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications

The Event

Event poster

ESC Congress 2024

1 September 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of late reperfusion therapy in patients with inferior ST-segment elevation myocardial infarction and right ventricular dysfunction: one size never fits all
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated in early hospital period
thumbnail
Congress Presentation
Effect of P2Y12 pretreatment on angiographic findings and in-hospital mortality in patients with ST-elevation myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources